Irritable bowel syndrome with constipation icd 10 cm
Irritable bowel syndrome with constipation icd 10 cm Irritable bowel syndrome with constipation icd 10 cm Irritable Bowel Syndrome with Constipation (IBS-C) is a common functional gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits, specifically constipation. It affects a significant portion of the population worldwide, impacting quality of life and daily functioning. Understanding its classification within the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM), is essential for accurate diagnosis, treatment, and health record management.
IBS-C falls under the broader category of disorders related to the gastrointestinal system, specifically under code K58. The specific ICD-10-CM code for Irritable Bowel Syndrome with Constipation is K58.0. This code is used by healthcare providers to document cases where a patient exhibits symptoms typical of IBS but predominantly struggles with constipation rather than diarrhea or mixed bowel habits. Proper coding ensures consistent communication across healthcare systems, facilitates epidemiological tracking, and supports insurance reimbursement processes.
The diagnostic criteria for IBS-C involve a combination of clinical symptoms and exclusion of other medical conditions. Patients typically report recurrent abdominal pain or discomfort, often relieved by defecation, along with infrequent or difficult bowel movements. Additional symptoms may include bloating, a sensation of incomplete evacuation, and hardened stool. Physicians rely on symptom-based criteria, such as the Rome IV criteria, to diagnose IBS-C accurately. Diagnostic workups often include ruling out other conditions like inflammatory bowel disease, celiac disease, or colorectal cancer through stool tests, blood work, and imaging studies.
Management of IBS-C involves a multifaceted approach tailored to individual patient needs. Dietary modifications, such as increasing fiber intake and avoiding trigger foods, can alleviate symptoms. Pharmacological therapies include laxatives, fiber supplements, and newer agents like lubiprostone or linaclotide, which enhance intestinal fluid secretion and motility. Additionally, lifestyle changes, stress management, and psychological therapies play crucial roles, considering the gut-brain axis’s influence on IBS.
Patient education is vital in managing IBS-C, helping individuals understand that while the condition may be chronic, symptoms can often be controlled effectively. Regular follow-up with healthcare providers ensures adjustments in treatment plans and addresses any emerging concerns. Moreover, understanding the ICD-10-CM coding system allows clinicians to document cases accurately, contribute to research data, and facilitate insurance claims.
In summary, IBS with constipation is a prevalent, complex disorder that requires a comprehensive approach for diagnosis and management. Proper coding with ICD-10-CM, specifically K58.0, ensures standardized documentation, which is essential for effective healthcare delivery and ongoing research into better treatment options. As awareness and understanding of IBS-C grow, so does the potential for improved quality of life for those affected by this challenging condition.
